All Industries

Top healthtech Companies

659 healthtech companies, sorted by total funding raised.

InvivydIPO

Biotechnology company developing antibody-based therapies against evolving viral threats includin...

Waltham, United States51–200healthtech, Biotech
Funding undisclosed
ArvinasIPO

Clinical-stage biotechnology company developing PROTAC protein degraders for oncology and neurode...

New Haven, United States201–500Biotech, Healthcare
Private Equity·$464.9M·Nov 2023
HeartFlowIPO

Heartflow’s vision is to transform CAD from the leading cause of death into a disease that can be...

San Francisco, United States501–1000Healthcare, healthtech
Convertible·$464.6M·Mar 2025
Nektar TherapeuticsIPO

Research-based development stage biopharmaceutical company that discovers and develops innovative...

San Francisco, United States51–200biotech, immunotherapy
Corporate Round·$460.0M·Feb 2026
AlumisIPO

Alumis is a late-stage biopharma company developing targeted therapies for patient with immune-me...

South San Francisco, United States201–500Life Sciences, healthtech
Series C·$459.0M·Mar 2024
Crinetics Pharmaceuticals, Inc.

R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.

San Diego, United States11–50Biotech, Healthcare
Venture Unknown·$453.5M·Jan 2026
Phathom PharmaceuticalsIPO

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing ...

Florham Park, United States201–500Biotech, GI Health
Venture Unknown·$450.3M·May 2023
X4 PharmaceuticalsIPO

Clinical-stage biopharmaceutical company developing novel, oral medicines designed to treat a ran...

Boston, United States51–200Biotech, Drug Discovery
Series C·$446.8M·Oct 2025
BioNTech

German biotech company developing mRNA-based immunotherapies and vaccines.

Mainz, Germany5001–10000Biotech, Healthcare
Series A·$425.0M·Jan 2019
Privia Health GroupIPO

Physician enablement platform delivering tools, talent, and technology to transform healthcare de...

Arlington, United States1001–5000healthtech
Private Equity·$417.5M·Sep 2014
BillionToOneIPO

The genetic testing platform detecting and measuring disease.

Menlo Park, United States201–500Diagnostics, Genomics
Venture Unknown·$406.0M·Mar 2026
Upstream BioIPO

Clinical-stage biotechnology company developing treatments for inflammatory diseases, with an ini...

Waltham, United States51–200healthtech, Biotech
Series B·$400.0M·Jun 2023
Rhythm PharmaceuticalsIPO

Biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases

Boston, United States201–500pharmaceuticals, healthtech
Extension Round·$398.0M·Jul 2025
ArcellxIPO

Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable...

Redwood City51–200Biopharmaceutical, Oncology
Seed·$375.0M·Jan 2024
MapLight TherapeuticsIPO

AI-powered neuroscience drug discovery platform for CNS diseases.

San Francisco, United States51–200Artificial Intelligence, Biotech
Series D·$372.5M·Jul 2025
Immatics N.V.IPO

Clinical-stage biopharmaceutical company developing T cell receptor-based adoptive cell therapies...

Tuebingen, Germany201–500healthtech, biotech
Corporate Round·$346.7M·Dec 2025
Prime MedicineIPO

Biotechnology company developing one-time curative genetic therapies using Prime Editing, a preci...

Cambridge, United States201–500Biotech, Healthcare
Grant·$339.0M·Jul 2025
Compass TherapeuticsIPO

Clinical-stage biotech developing novel antibody-based cancer therapies targeting the tumor micro...

Cambridge, United States11–50Biotech, Healthcare
Venture Unknown·$332.0M·Aug 2025
CryoPortIPO

World's largest manufacturer of cryogenic storage systems supporting clinical trials and commerci...

Nashville, United States501–1000healthtech, Biotech
Series C·$326.0M·Feb 2021
Corvus PharmaceuticalsIPO

Clinical-stage biopharmaceutical company focused on developing ITK inhibitor medicines for cancer...

Burlingame, United States11–50healthtech, Biotech
Corporate Round·$319.1M·Jan 2026
Zenas BioPharmaIPO

Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...

Boston, United States51–200Biotech, Healthcare
Series C·$318.0M·May 2024
Bicara TherapeuticsIPO

Clinical-stage biopharma developing dual-action biologics that combine targeted therapy and immun...

Cambridge, United States51–200Biotech, Healthcare
Series C·$313.0M·Dec 2023
NateraIPO

Natera provides DNA testing across multiple clinical areas including women’s health and oncology.

San Carlos, United States5001–10000Diagnostics, Genomics
Series E·$310.1M·Jul 2019
ArriVentIPO

Clinical-stage biopharma developing and commercializing oncology therapeutics, partnering to glob...

Newtown Square, United States11–50Life Sciences, Biotech
Series B·$305.0M·Mar 2023
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Series D·$300.0M·May 2020